Mercer Global Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,442
Closed -$345K 3250
2025
Q4
$345K Buy
22,442
+1,140
+5% +$12.6K ﹤0.01% 2128
2025
Q3
$212K Buy
+21,302
New +$222K ﹤0.01% 2356
2024
Q3
Sell
-200
Closed -$449K 1979
2024
Q2
$449K Buy
+200
New +$2.33K ﹤0.01% 1358

Other funds holding DVAX

Mercer Global Advisors's DVAX Position: Q1 2026 in Review

Mercer Global Advisors sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 22,442 shares — an estimated $345K sold.

Mercer Global Advisors first reported a position in DVAX in Q2 2024 and held it in 3 quarters. The position peaked at $449K in Q2 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Mercer Global Advisors reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Mercer Global Advisors sold 22,442 Dynavax Technologies shares in Q1 2026, an estimated $345K.
  • Mercer Global Advisors first reported a position in Dynavax Technologies in Q2 2024 and held it in 3 quarters.
  • Mercer Global Advisors's Dynavax Technologies position peaked at $449K in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.